Literature DB >> 22981874

The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.

Nicolas R Smoll1, Katharine J Drummond.   

Abstract

Medulloblastomas (MB) and primitive neurectodermal tumours (PNET) are known to affect children more than adults. To estimate the magnitude of the differences between the incidence of adults and children, the incidence rates, ratios and time trends of MB and PNET in children and adults are measured using data from the Surveillance, Epidemiology and End-Results (SEER) database. Between 1973 and 2007 in the SEER 9 registries, 1372 people were diagnosed with a MB and 530 with a PNET. The overall incidence rate of MB and PNET is approximately 1.5 and 0.62 per million population in the USA. Children (1-9 years of age) with MB had an incidence rate of 6.0, compared to 0.6 in adults, and therefore children are 10 times more likely to be affected by an MB than adults. Children are 4.6 times as likely to be afflicted by a PNET than adults. The difference in incidence rates based on sex existed only in children. Our study confirmed that the incidence rates of MB has not changed over time.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981874     DOI: 10.1016/j.jocn.2012.04.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  80 in total

1.  Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.

Authors:  Alexander L Chin; Everett J Moding; Sarah S Donaldson; Iris C Gibbs; Scott G Soltys; Susan M Hiniker; Erqi L Pollom
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

2.  PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.

Authors:  Yiliao Luo; Mengxing Li; Uday P Pratap; Suryavathi Viswanadhapalli; Junhao Liu; Prabhakar P Venkata; Kristin A Altwegg; Bridgitte E Palacios; Xiaonan Li; Yihong Chen; Manjeet K Rao; Andrew J Brenner; Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Mol Carcinog       Date:  2019-12-24       Impact factor: 4.784

3.  Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.

Authors:  Juan Yuan; Núria Llamas Luceño; Bjoern Sander; Monika M Golas
Journal:  Cell Oncol (Dordr)       Date:  2017-04-20       Impact factor: 6.730

4.  Incidence of medulloblastoma in Canadian children.

Authors:  Donna L Johnston; Daniel Keene; Maria Kostova; Douglas Strother; Lucie Lafay-Cousin; Chris Fryer; Katrin Scheinemann; Anne-Sophie Carret; Adam Fleming; Vanessa Percy; Samina Afzal; Beverly Wilson; Lynette Bowes; Shayna Zelcer; Chris Mpofu; Mariana Silva; Valerie Larouche; Josee Brossard; Eric Bouffet
Journal:  J Neurooncol       Date:  2014-08-17       Impact factor: 4.130

5.  Primary Sonic Hedgehog-activated dorsal brainstem medulloblastoma and ipsilateral cerebellar atrophy in an adult.

Authors:  Mustafa Kemal Demir; Özlem Yapıcıer; Basak Mert; Wiaam Alshareefi; Mustafa Bozbuğa
Journal:  Neuroradiol J       Date:  2019-11-27

6.  Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Authors:  Gabrielle Truitt; Haley Gittleman; Rebecca Leece; Quinn T Ostrom; Carol Kruchko; Terri S Armstrong; Mark R Gilbert; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2019-06-17       Impact factor: 4.130

7.  Epidemiology for primary brain tumors: a nationwide population-based study.

Authors:  Amélie Darlix; Sonia Zouaoui; Valérie Rigau; Faiza Bessaoud; Dominique Figarella-Branger; Hélène Mathieu-Daudé; Brigitte Trétarre; Fabienne Bauchet; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2016-11-16       Impact factor: 4.130

8.  Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.

Authors:  Vishesh Khanna; Rebecca L Achey; Quinn T Ostrom; Hunter Block-Beach; Carol Kruchko; Jill S Barnholtz-Sloan; Peter M de Blank
Journal:  J Neurooncol       Date:  2017-08-21       Impact factor: 4.130

9.  Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.

Authors:  Kavneet Kaur; Aanchal Kakkar; Anupam Kumar; Suvendu Purkait; Supriya Mallick; Vaishali Suri; Mehar C Sharma; Pramod K Julka; Deepak Gupta; Ashish Suri; Chitra Sarkar
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

Review 10.  Medulloblastoma.

Authors:  Nathan E Millard; Kevin C De Braganca
Journal:  J Child Neurol       Date:  2015-09-02       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.